Melasma Clinical Trial - Comparison Of Efficacy Of Combination Of TAM

See also
Status	Clinical Trial	Phase
Completed	`NCT05013801` - A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma	N/A
Recruiting	`NCT06174545` - Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma	N/A
Completed	`NCT01695356` - Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma	Phase 4
Recruiting	`NCT06278948` - Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma	N/A
Not yet recruiting	`NCT05911698` - Fractional co2 Laser Followed by Either Vitamin c or Tranexamic Acid in Treatment of Melasma.	N/A
Recruiting	`NCT05656833` - Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma	N/A
Recruiting	`NCT04597203` - Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial	N/A
Completed	`NCT02138539` - Evaluation of an Herbal-Based De-Pigmenting System	Phase 4
Recruiting	`NCT01661556` - Clinical Trial of Hydroquinone Versus Miconazol in Melasma	Phase 4
Completed	`NCT01001624` - Melanil in the Treatment of Melasma	Phase 3
Terminated	`NCT03415685` - Lutronic PicoPlus Exploratory Clinical Trial	N/A
Recruiting	`NCT04765930` - Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma	N/A
Completed	`NCT04137263` - Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging	N/A
Recruiting	`NCT03686787` - Oral Tranexamic Acid and Laser for Treatment of Melasma	Phase 4
Completed	`NCT05969587` - Cysteamine Compared to Hydroquinone in Melasma	Phase 3
Completed	`NCT00500162` - Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma	Phase 4
Completed	`NCT00472966` - Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma	Phase 4
Completed	`NCT05884151` - Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma	Phase 1
Completed	`NCT05887219` - Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma	Phase 1
Recruiting	`NCT03308370` - Platelet Rich Plasma in Treatment of Melasma	Phase 3

NCT number	NCT06013540
Study type	Interventional
Source	Jinnah Postgraduate Medical Centre
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	August 1, 2022
Completion date	August 30, 2023

Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms